Online citations, reference lists, and bibliographies.
← Back to Search

Calretinin Expression In Human Normal And Neoplastic Tissues: A Tissue Microarray Analysis On 5233 Tissue Samples.

A. Lugli, Yvonne Forster, P. Haas, A. Nocito, C. Bucher, H. Bissig, M. Mirlacher, M. Storz, M. Mihatsch, G. Sauter
Published 2003 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Calretinin is a calcium-binding protein expressed in different normal and neoplastic tissues. Early studies suggested that calretinin is a useful marker to differentiate adenocarcinomas from malignant mesotheliomas of the lung, but subsequent work has shown that calretinin can be expressed in several other tumor types. To systematically investigate the epidemiology of calretinin expression in normal and neoplastic tissues, we used tissue microarrays (TMAs) to analyze the immunohistochemically detectable expression of calretinin in 5233 tissue samples from 128 different tumor categories and 76 different normal tissue types. At least 1 case with weak expression could be found in 74 of 128 (58%) different tumor types and 46 entities (36%) had at least 1 tumor with strong positivity. In normal tissues, a particularly strong expression was found in Leydig cells of the testis, neurons of the brain, theca-lutein and theca interna cells of the ovary, and mesothelium. In tumors, strong calretinin expression was most frequently found in malignant mesotheliomas (6 of 7), Leydig cell tumors of the testis (5 of 5), adenomas of adrenal gland (5 of 9), and adenomatoid tumors (4 of 9). In summary, calretinin is frequently expressed in many different tumor types. Metastases of various different origins must be included in the differential diagnosis of calretinin-positive pleura tumors.
This paper references
10.1007/978-1-4684-5754-4_32
Calretinin and other CaBPs in the nervous system.
J. Rogers (1990)
10.1016/S0002-9440(10)63075-1
Tissue microarrays for rapid linking of molecular changes to clinical endpoints.
J. Torhorst (2001)
10.1002/path.893
Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies
L. Bubendorf (2001)
10.1016/S0002-9440(10)65349-7
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
H. Moch (1999)
10.1007/BF00185943
Parvalbumin and calretinin in the avian thymus
E. Király (2004)
10.1007/s005950200193
Mucinous Cystic Tumors of the Pancreas
T. Hara (2002)
10.1097/00000478-199807000-00009
Papillary carcinoma of the thymus: report of four cases of a new microscopic type of thymic carcinoma.
Y. Matsuno (1998)
[Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies].
M. Chenard-Neu (1998)
10.1007/BF00318606
Calcium-binding proteins: selective markers of nerve cells
C. Andressen (2004)
10.1016/0167-4781(94)90069-8
Calretinin is expressed in the Leydig cells of rat testis.
K. Strauss (1994)
10.1159/000333181
Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
M. Barberis (1997)
10.1097/00000478-199904000-00005
Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors.
G. Zamboni (1999)
10.1146/annurev.bi.45.070176.001323
Calcium-binding proteins.
R. Kretsinger (1976)
10.1016/0736-5748(95)00048-L
Calretinin immunoreactivity in adrenal glands of developing, adult and ageing Sprague-Dawley rats
M. Afework (1995)
10.1309/NR6G-T872-F090-LBRW
Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations.
L. Terracciano (2000)
10.1309/XL6K-8E62-9FLD-V8Q8
Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies.
F. Roberts (2001)
10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
A. Nocito (2001)
10.1016/S0344-0338(96)80208-1
The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
V. Gotzos (1996)
10.1097/00000478-200101000-00004
Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung Adenocarcinoma: A Study With Logistic Regression Analysis
R. Carella (2001)
10.1046/j.1365-2559.2000.00770.x
HBME‐1, MOC‐31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma
Oates (2000)
10.1007/s004180050202
Selective immunocytochemical localisation of calretinin in the human ovary
S. Bertschy (1997)
10.1097/00000478-199609000-00001
Calretinin: a novel immunocytochemical marker for mesothelioma.
C. Doglioni (1996)
10.1111/J.1432-1033.1991.TB15788.X
Structure of the human brain calcium-binding protein calretinin and its expression in bacteria.
M. Parmentier (1991)
Tissue microarrays for gene amplification surveys in many different tumor types.
P. Schraml (1999)
10.1097/00000478-199906000-00010
Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues.
V. Gotzos (1999)
10.1097/00004347-200110000-00006
Expression of Calretinin in Human Ovary, Testis, and Ovarian Sex Cord-Stromal Tumors
Q. Cao (2001)
10.1016/S0344-0338(98)80065-4
The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology.
H. Nagel (1998)
10.1038/NM0798-844
Tissue microarrays for high-throughput molecular profiling of tumor specimens
J. Kononen (1998)
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
R. Simon (2001)
10.1309/QHCA-8594-TA7P-0DVQ
An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma.
U. Brockstedt (2000)
10.1038/modpathol.3880018
Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura
P. Cury (2000)
10.1076/EJOM.35.3.137.13072
Calretinin is transiently expressed in tendon fibroblasts of the paravertebral region of the chick embryo.
V. Gangji (1997)
10.1046/j.1365-2559.2000.00981.x
Anti‐mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms
R. Attanoos (2000)
10.1046/j.1365-2559.2000.00940.x
Calretinin expression in ameloblastomas
M. Altini (2000)
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells.
R. Simon (2001)



This paper is referenced by
Adrenocortical Neoplasms
S. Lau (2005)
10.1016/j.humpath.2012.05.014
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
N. Ordóñez (2013)
10.1155/2014/308240
Calretinin as a Diagnostic Adjunct for Ameloblastoma
C. Anandani (2014)
10.1111/j.1365-2559.2007.02948.x
Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis
M. Alaeddini (2008)
10.1136/jcp.2006.039917
Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis
P. Mhawech-Fauceglia (2006)
10.23958/ijirms/vol04-i01/550
Expression of Mesothelial Marker Calretinin in Breast Cancer
Kalathingal Kamarunisha Aboobacker (2019)
10.5603/FHC.a2014.0036
Inhibin-α, E-cadherin, calretinin and Ki-67 antigen in the immunohistochemical evaluation of canine and human testicular neoplasms.
Rafał Ciaputa (2014)
10.1097/PAS.0b013e318188373d
Identification of the Most Sensitive and Robust Immunohistochemical Markers in Different Categories of Ovarian Sex Cord-stromal Tumors
C. Zhao (2009)
10.1016/J.HUMPATH.2005.11.006
Calretinin expression in tumors of adipose tissue.
J. Cates (2006)
10.1177/1010428317712166
Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers
F. Person (2017)
10.1038/modpathol.3800544
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study
N. Ordóñez (2006)
10.1111/j.1440-1827.2005.01838.x
Large cell calcifying Sertoli cell tumor of the testis: Comparative immunohistochemical study with Leydig cell tumor
Katsuaki Sato (2005)
Molecular Biomarkers and Network Analyses of Neuron-type Connectivity Reveal Cloaked Insights into Hippocampal Function
C. L. Rees (2016)
10.1017/CBO9781316167366.005
Tumors of the endocrine system
P. Chu (2014)
10.1097/01.pas.0000213355.72638.f4
Comparative Analysis of Alternative and Traditional Immunohistochemical Markers for the Distinction of Ovarian Sertoli Cell Tumor From Endometrioid Tumors and Carcinoid Tumor: A Study of 160 Cases
C. Zhao (2007)
10.1002/1878-0261.12749
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
Kaire Ojasalu (2020)
10.1043/1543-2165(2008)132[1062:IOPAPN]2.0.CO;2
Immunohistochemistry of pulmonary and pleural neoplasia.
M. Beasley (2008)
10.1016/j.prp.2016.07.010
Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
V. Ascoli (2016)
10.1097/PAS.0000000000000233
Best Practices Recommendations in the Application of Immunohistochemistry in Testicular Tumors: Report From the International Society of Urological Pathology Consensus Conference
T. Ulbright (2014)
10.1111/aji.12416
Interleukin‐2 Production by Cultured Human Granulosa Cells
R. Orvieto (2015)
10.1158/0008-5472.CAN-08-0047
Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy.
T. Fukazawa (2008)
10.1097/01.pgp.0000139644.38835.9d
An Immunohistochemical Analysis of Ovarian Small Cell Carcinoma of Hypercalcemic Type
W. G. McCluggage (2004)
10.1002/ELAN.201500324
Quantitative Analysis of a Promising Cancer Biomarker, Calretinin, by a Biosensing System Based on Simple and Effective Immobilization Process
Engin Asav (2016)
10.1007/S00120-006-1162-Z
[Adenomatoid tumor of the testes--a rare entity. Clinical, diagnostic and therapeutic aspects].
M. Lehsnau (2006)
10.1111/j.1440-1827.2008.02309.x
Pleomorphic carcinoma of the lung expressing podoplanin and calretinin
H. Kenmotsu (2008)
10.1007/978-90-481-2918-8_14
Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry
Fanny Burel-Vandenbos (2010)
10.1007/978-1-4419-0489-8_14
Surface Epithelial Tumors of the Ovary
J. Seidman (2011)
10.1177/1066896916664988
Identification of Signet Ring Cell Change in Colonic Subserosa in the Setting of Clostridium difficile Colitis
O. Khan (2017)
10.1038/modpathol.2010.46
The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin
M. Mahalingam (2010)
10.4103/jomfp.JOMFP_54_19
Calretinin expression in odontogenic cysts and odontogenic tumors and the possible role of calretinin in pathogenesis of ameloblastoma
Amrutha Rudraraju (2019)
10.1053/J.SEMDP.2005.11.003
The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis.
R. Emerson (2005)
10.1111/j.1365-2559.2007.02620.x
Prognostic significance of the wnt signalling pathway molecules APC, β‐catenin and E‐cadherin in colorectal cancer—a tissue microarray‐based analysis
A. Lugli (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar